Saturday 17 October 2026
Export OGI’s income statement to Excel — free account
Organigram Global Inc.
OGI Healthcare Drug Manufacturers Specialty & Generic
Organigram Global Inc.’s revenue for fiscal 2025 (year ended September 2025) was $185.3 million, up 57.7% from fiscal 2024. In the quarter to June 2026, revenue grew 49.3%, EPS grew 1,966.7% and free cash flow fell 192.3%, each against the same quarter a year earlier.
0.93
0.00
0.00%
Follow OGI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 5 | 4 | 4 |
| (7.46%) | 5.25% | (6.34%) | 20.20% | ||
| (5.05%) | 3.60% | (4.56%) | 12.70% | ||
ROIC |
(3.61%) | (1.51%) | (3.94%) | (1.53%) | |
Return on Tangible Assets |
(8.79%) | 6.35% | (8.37%) | 29.94% | |
Average Days of Receivables |
91.34 | 65.26 | 71.65 | 104.53 | |
Free Cash Flow per Share |
(0.14) | (0.20) | (0.12) | (0.16) | |
Free Cash Flow |
(17.54) | (26.36) | (15.72) | (21.14) | |
Capital Expenditures |
(12.11) | (12.44) | (8.15) | (0.60) | |
| Other line items | |||||
Cash ROIC |
(5.66%) | (8.50%) | (5.05%) | (5.65%) | |
Accounts Receivable Turnover |
5.03 | 5.77 | 5.38 | 4.23 | |
Accounts Payable Turnover |
2.45 | 2.68 | 2.63 | 2.07 | |
Inventory Turnover |
1.62 | 1.52 | 1.43 | 1.35 | |
Average Days of Payables |
192.79 | 144.27 | 152.30 | 185.58 | |
Days of Inventory on Hand |
267.76 | 269.36 | 281.45 | 306.51 | |
Tax Rate |
(0.36) | 0.00 | 0.00 | 0.18 | |
Research and Development Expense of Revenue |
4.22% | 3.81% | 3.66% | 3.07% | |
Selling, General and Administrative Expense of Revenue |
36.49% | 36.07% | 37.14% | 35.65% | |
Share Based Compensation of Revenue |
1.63% | 1.31% | 1.28% | 1.17% | |
Operating CF/Net income |
0.31 | (1.07) | 0.44 | (0.32) | |
Depreciation/Fixed assets |
0.15 | 0.16 | 0.16 | 0.21 | |
Capex/Depreciation |
(0.94) | (0.89) | (0.57) | (0.03) | |
Revenue per Share |
1.45 | 1.49 | 1.51 | 1.65 | |
Operating CF per Share |
(0.04) | (0.10) | (0.06) | (0.15) | |
Capex per Share |
(0.09) | (0.09) | (0.06) | 0.00 | |
Capex to Sales |
0.07 | 0.06 | 0.04 | 0.00 |
Columns are period end dates